CDK7 inhibitors as anticancer drugs

GP Sava, H Fan, RC Coombes, L Buluwela… - Cancer and Metastasis …, 2020 - Springer
Abstract Cyclin-dependent kinase 7 (CDK7), along with cyclin H and MAT1, forms the CDK-
activating complex (CAK), which directs progression through the cell cycle via T-loop …

UV-induced molecular signaling differences in melanoma and non-melanoma skin cancer

F Liu-Smith, J Jia, Y Zheng - Ultraviolet light in human health, diseases …, 2017 - Springer
There are three major types of skin cancer: melanoma, basal cell carcinoma (BCC) and
squamous cell carcinoma (SCC). BCC and SCC are often referred to as non-melanoma skin …

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

S Yokoyama, SL Woods, GM Boyle, LG Aoude… - Nature, 2011 - nature.com
So far, two genes associated with familial melanoma have been identified, accounting for a
minority of genetic risk in families. Mutations in CDKN2A account for approximately 40% of …

[HTML][HTML] BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma

EE Patton, HR Widlund, JL Kutok, KR Kopani… - Current Biology, 2005 - cell.com
Melanoma is the most lethal form of skin cancer, and the incidence and mortality rates are
rapidly rising. Epidemiologically, high numbers of nevi (moles) are associated with higher …

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

KS Hoek, NC Schlegel, P Brafford, A Sucker… - Pigment cell …, 2006 - Wiley Online Library
The molecular biology of metastatic potential in melanoma has been studied many times
previously and changes in the expression of many genes have been linked to metastatic …

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

LH Saal, P Johansson, K Holm… - Proceedings of the …, 2007 - National Acad Sciences
Pathway-specific therapy is the future of cancer management. The oncogenic
phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in solid tumors; …

Gene expression profiling of primary cutaneous melanoma and clinical outcome

V Winnepenninckx, V Lazar, S Michiels… - Journal of the …, 2006 - academic.oup.com
Background: Gene expression profiling data for human primary cutaneous melanomas are
scarce because of the lack of retrospective collections of frozen tumors. To identify …

Gene expression profiling–based identification of molecular subtypes in stage IV melanomas with different clinical outcome

G Jönsson, C Busch, S Knappskog, J Geisler… - Clinical cancer …, 2010 - AACR
Purpose: The incidence of malignant melanoma is increasing worldwide in fair-skinned
populations. Melanomas respond poorly to systemic therapy, and metastatic melanomas …

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray …

TJ Giordano, R Kuick, DG Thomas, DE Misek, M Vinco… - Oncogene, 2005 - nature.com
Thyroid cancer poses a significant clinical challenge, and our understanding of its
pathogenesis is incomplete. To gain insight into the pathogenesis of papillary thyroid …

Identification of a Poor-Prognosis BRAF-Mutant–Like Population of Patients With Colon Cancer

V Popovici, E Budinska, S Tejpar, S Weinrich… - Journal of clinical …, 2012 - ascopubs.org
Purpose Our purpose was development and assessment of a BRAF-mutant gene
expression signature for colon cancer (CC) and the study of its prognostic implications …